Clinical trial
Risk, Predictors, Impact and Outcome of Anticoagulation-associated Abnormal Menstrual Bleeding in Female Patients With VTE
NCT04748393 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Risk, Predictors, Impact and Outcome of Anticoagulation-associated Abnormal Menstrual Bleeding in Female Patients With VTE
- Lead sponsor
- Leiden University Medical Center
- Phase
- Observational
- Overall status
- Terminated
- Start date
- September 1, 2018
- Completion date
- February 1, 2021
- Enrollment
- 90 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.